Rush Children’s Hospital in Chicago, Illinois, offers comprehensive diagnostic and treatment programs for children with hematologic and oncologic disorders. Our staff includes some of the nation’s foremost experts in the treatment of pediatric blood disorders and cancers. To provide the very best care for children, physicians in the Section of Pediatric Hematology-Oncology work collaboratively with physicians throughout Rush University Medical Center, including experts in orthopedic oncology, pediatric surgery and bone marrow transplant.

We offer the following programs to help your child:

• Hemophilia and Thrombophilia Treatment Center: This federally funded center offers comprehensive treatment for children and adults with hemophilia, von Willebrand disease and other bleeding disorders, as well as a wide range of clotting disorders.
• Sickle Cell Disease Program: This program provides care for children with sickle cell disease and thallasemias.
• Bone and Soft Tissue Sarcoma Program and the Leukemia and Lymphoma Disease Program: These programs provide diagnostic, consultative services and disease management for the entire spectrum of solid tumors, leukemia and lymphoma.

In collaboration with the Bone Marrow Treatment Program, we also provide care for children and adolescents receiving high-dose therapy and stem cell transplantation. Rush has the only transplant program in Illinois certified by the National Marrow Donor Program to perform unrelated donor marrow transplantation. Rush also performs peripheral blood and umbilical cord stem cell transplant for a variety of malignant and nonmalignant disorders.

In addition to the three locations below, we see patients at offices at Riverside Medical Center in Kankakee.

Our physicians are among the most prominent childhood cancer specialists in the United States.

• Leonard A. Valentino, MD, a physician with nearly 20 years experience with bleeding and clotting disorders, is director of the Section of Pediatric Hematology-Oncology. Dr. Valentino also directs the Hemophilia and Thrombophilia Treatment Center.
• Allen Korenblit, MD, brings more than 20 years experience to the treatment of pediatric blood disorders and cancer. Dr. Korenblit directs the Sickle Cell Disease Program, the Bone and Soft Tissue Sarcoma Program and the Leukemia and Lymphoma Disease Program.

Our faculty members belong to the Children’s Oncology Group, a National Cancer Institute-supported clinical trials cooperative group devoted exclusively to childhood and adolescent cancer research. The research includes phase I, II and III studies involving patients with a variety of cancers, including Ewing sarcoma, Hodgkin disease, leukemia, Wilms tumor, medulloblastoma, neuroblastoma and lymphoma. Allen Korenblit, MD, is principal investigator at Rush for the pediatric oncology group.